Yebo Fu

663 total citations
10 papers, 551 citations indexed

About

Yebo Fu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yebo Fu has authored 10 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Yebo Fu's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Yebo Fu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Yebo Fu collaborates with scholars based in United States and China. Yebo Fu's co-authors include Sidney W. Fu, Liang Chen, Wendy Wang, Rachel F. Brem, Christine Teal, Katayoon Rezaei, Xiaohui Tan, Yan‐Gao Man, Sana Tabbara and Shejuan An and has published in prestigious journals such as PLoS ONE, Cancer Research and Acta Biomaterialia.

In The Last Decade

Yebo Fu

10 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yebo Fu United States	9	396	360	110	59	28	10	551
Roberto Sessa Italy	14	408 1.0×	219 0.6×	138 1.3×	68 1.2×	13 0.5×	16	656
Qiqi Liu China	10	378 1.0×	183 0.5×	62 0.6×	62 1.1×	50 1.8×	21	493
Minkoo Seo South Korea	8	449 1.1×	221 0.6×	94 0.9×	57 1.0×	48 1.7×	10	560
Clotilde Costa Spain	15	367 0.9×	278 0.8×	314 2.9×	146 2.5×	14 0.5×	31	677
Ruobing Jia China	10	500 1.3×	299 0.8×	87 0.8×	10 0.2×	31 1.1×	14	590
Baoshun Lin China	6	280 0.7×	112 0.3×	102 0.9×	22 0.4×	40 1.4×	8	386
Krishna K. Kolluri United Kingdom	12	336 0.8×	157 0.4×	91 0.8×	68 1.2×	39 1.4×	22	537
Garima Kaushik United States	7	221 0.6×	114 0.3×	176 1.6×	65 1.1×	18 0.6×	12	409
Karla G. Contreras Australia	8	253 0.6×	88 0.2×	68 0.6×	46 0.8×	45 1.6×	11	397
Maayan Pour Israel	8	259 0.7×	95 0.3×	111 1.0×	59 1.0×	18 0.6×	8	380

Countries citing papers authored by Yebo Fu

Since Specialization

Citations

This map shows the geographic impact of Yebo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yebo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yebo Fu more than expected).

Fields of papers citing papers by Yebo Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yebo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yebo Fu. The network helps show where Yebo Fu may publish in the future.

Co-authorship network of co-authors of Yebo Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yebo Fu. A scholar is included among the top collaborators of Yebo Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yebo Fu. Yebo Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Tan, Xiaohui, Yebo Fu, Liang Chen, et al.. (2015). Abstract 3062: miR-671-5p promotes epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Cancer Research. 75(15_Supplement). 3062–3062. 2 indexed citations

2.

Tan, Xiaohui, Yebo Fu, Liang Chen, et al.. (2015). miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 7(1). 293–307. 80 indexed citations

3.

Chen, Liang, Shejuan An, Xiaohui Tan, et al.. (2014). MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma. Journal of Cancer. 5(9). 804–812. 29 indexed citations

4.

Tan, Xiaohui, Jin Peng, Yebo Fu, et al.. (2014). miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer. Breast Cancer Research. 16(5). 435–435. 105 indexed citations

5.

Zhu, Wei, Mian Wang, Yebo Fu, et al.. (2014). Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study. Acta Biomaterialia. 14. 164–174. 69 indexed citations

6.

Chen, Liang, Yebo Fu, Michael Stamatakos, et al.. (2013). Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue. PLoS ONE. 8(1). e54213–e54213. 94 indexed citations

7.

Chen, Liang, et al.. (2012). Cell-free Circulating miRNA Biomarkers in Cancer. Journal of Cancer. 3. 432–448. 127 indexed citations

8.

Fu, Yebo, Lei Zhang, Yan‐Gao Man, et al.. (2010). BP1, an Isoform of DLX4 Homeoprotein, Negatively Regulates BRCA1 in Sporadic Breast Cancer. International Journal of Biological Sciences. 6(5). 513–524. 15 indexed citations

9.

Fu, Yebo, Kyung Soon Kim, Lei Zhang, et al.. (2010). BP1 Homeoprotein Enhances Metastatic Potential in ER-negative Breast Cancer. Journal of Cancer. 1. 54–62. 19 indexed citations

10.

Song, Yongchun, et al.. (2009). Genome-wide Analysis of BP1 Transcriptional Targets in Breast Cancer Cell Line Hs578T. International Journal of Biological Sciences. 5(1). 1–12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact